SAP-话题@MedSci - 梅斯（MedSci）

#SAP#

32篇内容 | 1968人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1898182, encodeId=3183189818242, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=JACC：使用爱德华兹Sapien瓣膜的经导管肺动脉瓣植入术, objectType=article, longId=150336, objectId=a0d5150336ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0d5150336ac, replyNumber=0, likeNumber=0, createdTime=2019-08-23, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0d5150336ac, moduleTitle=JACC：使用爱德华兹Sapien瓣膜的经导管肺动脉瓣植入术, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a0d5150336ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898183, encodeId=97e3189818326, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=JACC：爱德华兹Sapien经导管心脏瓣膜治疗肺部导管失效的3年结局, objectType=article, longId=150465, objectId=7ea21504657b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ea21504657b, replyNumber=0, likeNumber=65, createdTime=2019-03-04, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ea21504657b, moduleTitle=JACC：爱德华兹Sapien经导管心脏瓣膜治疗肺部导管失效的3年结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7ea21504657b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898178, encodeId=080718981e82c, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=JACC：使用SAPIEN 3瓣膜经导管主动脉瓣置换术的性别特异性结局, objectType=article, longId=125404, objectId=f948125404c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f948125404c0, replyNumber=0, likeNumber=83, createdTime=2018-12-03, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f948125404c0, moduleTitle=JACC：使用SAPIEN 3瓣膜经导管主动脉瓣置换术的性别特异性结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f948125404c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898177, encodeId=ee2318981e7e0, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=SAPHO综合征并严重骨质疏松症一例, objectType=article, longId=101623, objectId=3bd7101623c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bd7101623c4, replyNumber=0, likeNumber=70, createdTime=2017-07-02, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bd7101623c4, moduleTitle=SAPHO综合征并严重骨质疏松症一例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3bd7101623c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898176, encodeId=5f0c18981e604, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=聚焦|上海CMEF会议论坛：如何应对MDSAP审核, objectType=article, longId=98902, objectId=99d698902ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99d698902ce, replyNumber=0, likeNumber=74, createdTime=2017-05-21, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99d698902ce, moduleTitle=聚焦|上海CMEF会议论坛：如何应对MDSAP审核, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=99d698902ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898175, encodeId=34a118981e53a, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=Crit Care：SAPS II和SAPS3死亡评分校准的决定因素有哪些？, objectType=article, longId=94653, objectId=c8829465301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8829465301, replyNumber=0, likeNumber=72, createdTime=2017-04-13, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8829465301, moduleTitle=Crit Care：SAPS II和SAPS3死亡评分校准的决定因素有哪些？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c8829465301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898174, encodeId=4a5618981e434, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=SAPHO综合征特征，影像学表现, objectType=article, longId=67784, objectId=b4516e7848e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4516e7848e, replyNumber=0, likeNumber=94, createdTime=2016-10-28, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4516e7848e, moduleTitle=SAPHO综合征特征，影像学表现, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b4516e7848e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898173, encodeId=94c618981e347, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=EASL 2014：丙肝药物试验大放光彩（SAPPHIRE试验）, objectType=article, longId=33206, objectId=e37f3320613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37f3320613, replyNumber=0, likeNumber=71, createdTime=2014-09-26, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37f3320613, moduleTitle=EASL 2014：丙肝药物试验大放光彩（SAPPHIRE试验）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e37f3320613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898171, encodeId=a44218981e19c, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=FDA批准人工心脏瓣Sapien THV用于不适合手术的主动脉瓣狭窄患者, objectType=article, longId=25006, objectId=7a1e2500636, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a1e2500636, replyNumber=0, likeNumber=105, createdTime=2013-12-27, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a1e2500636, moduleTitle=FDA批准人工心脏瓣Sapien THV用于不适合手术的主动脉瓣狭窄患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7a1e2500636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898172, encodeId=011118981e231, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=GSK治疗杜氏肌营养不良药物drisapersen三期研究失败, objectType=article, longId=25276, objectId=53ac252e684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ac252e684, replyNumber=0, likeNumber=73, createdTime=2014-04-10, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ac252e684, moduleTitle=GSK治疗杜氏肌营养不良药物drisapersen三期研究失败, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=53ac252e684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898170, encodeId=d02e18981e0a4, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=FDA扩大Sapien人工瓣膜适应证, objectType=article, longId=10559, objectId=77af10559a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77af10559a7, replyNumber=0, likeNumber=88, createdTime=2013-04-14, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77af10559a7, moduleTitle=FDA扩大Sapien人工瓣膜适应证, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=77af10559a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1898169, encodeId=2e8b1898169ae, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, objectTitle=Sapien瓣膜的研究达到了安全终点和疗效终点，但患者卒中风险增加, objectType=article, longId=7709, objectId=0f3be70920, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f3be70920, replyNumber=0, likeNumber=74, createdTime=2012-09-30, rootId=0, userName=zz70, userId=30f5146, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f3be70920, moduleTitle=Sapien瓣膜的研究达到了安全终点和疗效终点，但患者卒中风险增加, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0f3be70920)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SAP

2020-05-29

zz70 (审核中...)

前往app查看评论内容

#SAP#

JACC：使用爱德华兹Sapien瓣膜的经导管肺动脉瓣植入术

2019-08-23

zz70 (审核中...)

前往app查看评论内容

#SAP#

JACC：爱德华兹Sapien经导管心脏瓣膜治疗肺部导管失效的3年结局

2019-03-04

zz70 (审核中...)

前往app查看评论内容

#SAP#

JACC：使用SAPIEN 3瓣膜经导管主动脉瓣置换术的性别特异性结局

2018-12-03

zz70 (审核中...)

前往app查看评论内容

#SAP#

SAPHO综合征并严重骨质疏松症一例

2017-07-02

zz70 (审核中...)

前往app查看评论内容

#SAP#

聚焦|上海CMEF会议论坛：如何应对MDSAP审核

2017-05-21

zz70 (审核中...)

前往app查看评论内容

#SAP#

Crit Care：SAPS II和SAPS3死亡评分校准的决定因素有哪些？

2017-04-13

zz70 (审核中...)

前往app查看评论内容

#SAP#

SAPHO综合征特征，影像学表现

2016-10-28

zz70 (审核中...)

前往app查看评论内容

#SAP#

EASL 2014：丙肝药物试验大放光彩（SAPPHIRE试验）

2014-09-26

zz70 (审核中...)

前往app查看评论内容

#SAP#

FDA批准人工心脏瓣Sapien THV用于不适合手术的主动脉瓣狭窄患者

2013-12-27

zz70 (审核中...)

前往app查看评论内容

#SAP#

GSK治疗杜氏肌营养不良药物drisapersen三期研究失败

2014-04-10

zz70 (审核中...)

前往app查看评论内容

#SAP#

FDA扩大Sapien人工瓣膜适应证

2013-04-14

zz70 (审核中...)

前往app查看评论内容

#SAP#

Sapien瓣膜的研究达到了安全终点和疗效终点，但患者卒中风险增加

2012-09-30

科室
- - 订阅+
  - 更多科室
工具
服务